Labcorp Holdings annual net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Net Income Growth & History (LH)
Labcorp Holdings's net income was $876.5M for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $876.5M | $130.5M | +17.49% |
| 2024 | 2024-12-31 | $746.0M | $328.0M | +78.47% |
| 2023 | 2023-12-31 | $418.0M | −$861.1M | −67.32% |
| 2022 | 2022-12-31 | $1.28B | −$1.10B | −46.20% |
| 2021 | 2021-12-31 | $2.38B | $821.2M | +52.77% |
| 2020 | 2020-12-31 | $1.56B | $732.3M | +88.89% |
| 2019 | 2019-12-31 | $823.8M | −$59.9M | −6.78% |
| 2018 | 2018-12-31 | $883.7M | −$343.4M | −27.98% |
| 2017 | 2017-12-31 | $1.23B | $515.3M | +72.39% |
| 2016 | 2016-12-31 | $711.8M | $274.2M | +62.66% |
| 2015 | 2015-12-31 | $437.6M | −$73.6M | −14.40% |
| 2014 | 2014-12-31 | $511.2M | −$62.6M | −10.91% |
| 2013 | 2013-12-31 | $573.8M | −$9.3M | −1.59% |
| 2012 | 2012-12-31 | $583.1M | $63.4M | +12.20% |
| 2011 | 2011-12-31 | $519.7M | −$38.5M | −6.90% |
| 2010 | 2010-12-31 | $558.2M | $14.9M | +2.74% |
| 2009 | 2009-12-31 | $543.3M | $78.8M | +16.96% |
| 2008 | 2008-12-31 | $464.5M | −$12.3M | −2.58% |
| 2007 | 2007-12-31 | $476.8M | — | — |
Labcorp Holdings quarterly net income
Q2.08
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $298.7M | $60.8M | +25.56% |
| Q1 2026 | 2026-03-31 | $277.8M | $65.0M | +30.55% |
| Q4 2025 | 2025-12-31 | $164.7M | $21.3M | +14.85% |
| Q3 2025 | 2025-09-30 | $261.1M | $91.8M | +54.22% |
| Q2 2025 | 2025-06-30 | $237.9M | $32.6M | +15.88% |
| Q1 2025 | 2025-03-31 | $212.8M | −$15.2M | −6.67% |
| Q4 2024 | 2024-12-31 | $143.4M | $310.5M | — |
| Q3 2024 | 2024-09-30 | $169.3M | −$14.0M | −7.64% |
| Q2 2024 | 2024-06-30 | $205.3M | $16.4M | +8.68% |
| Q1 2024 | 2024-03-31 | $228.0M | $15.1M | +7.09% |
| Q4 2023 | 2023-12-31 | −$167.1M | −$243.2M | — |
| Q3 2023 | 2023-09-30 | $183.3M | −$169.5M | −48.04% |
| Q2 2023 | 2023-06-30 | $188.9M | −$169.7M | −47.32% |
| Q1 2023 | 2023-03-31 | $212.9M | −$278.7M | −56.69% |
| Q4 2022 | 2022-12-31 | $76.1M | −$476.9M | −86.24% |
| Q3 2022 | 2022-09-30 | $352.8M | −$234.5M | −39.93% |
| Q2 2022 | 2022-06-30 | $358.6M | −$108.8M | −23.28% |
| Q1 2022 | 2022-03-31 | $491.6M | −$278.0M | −36.12% |
| Q4 2021 | 2021-12-31 | $553.0M | −$385.3M | −41.06% |
| Q3 2021 | 2021-09-30 | $587.3M | −$116.1M | −16.51% |
| Q2 2021 | 2021-06-30 | $467.4M | $235.8M | +101.81% |
| Q1 2021 | 2021-03-31 | $769.6M | $1.09B | — |
| Q4 2020 | 2020-12-31 | $938.3M | $711.2M | +313.17% |
| Q3 2020 | 2020-09-30 | $703.4M | $1.02B | — |
| Q2 2020 | 2020-06-30 | $231.6M | $41.2M | +21.64% |
| Q1 2020 | 2020-03-31 | −$317.2M | −$502.8M | — |
| Q4 2019 | 2019-12-31 | $227.1M | $69.2M | +43.83% |
| Q3 2019 | 2019-09-30 | −$317.2M | −$636.0M | — |
| Q2 2019 | 2019-06-30 | $190.4M | −$43.4M | −18.56% |
| Q1 2019 | 2019-03-31 | $185.6M | $12.4M | +7.16% |
| Q4 2018 | 2018-12-31 | $157.9M | −$529.9M | −77.04% |
| Q3 2018 | 2018-09-30 | $318.8M | $147.3M | +85.89% |
| Q2 2018 | 2018-06-30 | $233.8M | $49.0M | +26.52% |
| Q1 2018 | 2018-03-31 | $173.2M | −$9.8M | −5.36% |
| Q4 2017 | 2017-12-31 | $687.8M | $503.4M | +272.99% |
| Q3 2017 | 2017-09-30 | $171.5M | −$8.0M | −4.46% |
| Q2 2017 | 2017-06-30 | $184.8M | −$19.3M | −9.46% |
| Q1 2017 | 2017-03-31 | $183.0M | $18.9M | +11.52% |
| Q4 2016 | 2016-12-31 | $184.4M | $74.4M | +67.64% |
| Q3 2016 | 2016-09-30 | $179.5M | $24.8M | +16.03% |
| Q2 2016 | 2016-06-30 | $204.1M | $34.2M | +20.13% |
| Q1 2016 | 2016-03-31 | $164.1M | $161.1M | +5370.00% |
| Q4 2015 | 2015-12-31 | $110.0M | −$9.6M | −8.03% |
| Q3 2015 | 2015-09-30 | $154.7M | $17.5M | +12.76% |
| Q2 2015 | 2015-06-30 | $169.9M | $28.6M | +20.24% |
| Q1 2015 | 2015-03-31 | $3.0M | −$508.2M | −99.41% |
| Q4 2014 | 2014-12-31 | $119.6M | −$6.8M | −5.38% |
| Q3 2014 | 2014-09-30 | $137.2M | −$11.1M | −7.48% |
| Q2 2014 | 2014-06-30 | $141.3M | −$10.6M | −6.98% |
| Q1 2014 | 2014-03-31 | $511.2M | $364.0M | +247.28% |
| Q4 2013 | 2013-12-31 | $126.4M | $6.2M | +5.16% |
| Q3 2013 | 2013-09-30 | $148.3M | $300,000 | +0.20% |
| Q2 2013 | 2013-06-30 | $151.9M | −$1.4M | −0.91% |
| Q1 2013 | 2013-03-31 | $147.2M | −$14.4M | −8.91% |
| Q4 2012 | 2012-12-31 | $120.2M | −$15.2M | −11.23% |
| Q3 2012 | 2012-09-30 | $148.0M | $13.7M | +10.20% |
| Q2 2012 | 2012-06-30 | $153.3M | $30.4M | +24.74% |
| Q1 2012 | 2012-03-31 | $161.6M | $34.5M | +27.14% |
| Q4 2011 | 2011-12-31 | $135.4M | $3.6M | +2.73% |
| Q3 2011 | 2011-09-30 | $134.3M | −$5.7M | −4.07% |
| Q2 2011 | 2011-06-30 | $122.9M | −$30.8M | −20.04% |
| Q1 2011 | 2011-03-31 | $127.1M | −$5.6M | −4.22% |
| Q4 2010 | 2010-12-31 | $131.8M | −$10.9M | −7.64% |
| Q3 2010 | 2010-09-30 | $140.0M | $8.6M | +6.54% |
| Q2 2010 | 2010-06-30 | $153.7M | $17.3M | +12.68% |
| Q1 2010 | 2010-03-31 | $132.7M | −$100,000 | −0.08% |
| Q4 2009 | 2009-12-31 | $142.7M | — | — |
| Q3 2009 | 2009-09-30 | $131.4M | $19.5M | +17.43% |
| Q2 2009 | 2009-06-30 | $136.4M | $32.2M | +30.90% |
| Q1 2009 | 2009-03-31 | $132.8M | — | — |
| Q3 2008 | 2008-09-30 | $111.9M | — | — |
| Q2 2008 | 2008-06-30 | $104.2M | — | — |
Labcorp Holdings net income trends
Over the last five fiscal years, Labcorp Holdings's net income decreased from $1.56B to $876.5M, a change of −$679.6M. The latest reported quarter, Q2 2026, shows $298.7M.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...